In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
Annabel Blasi, Fien A. von Meijenfeldt, Jelle Adelmeijer, Andrea Calvo, Cristina Ibáñez, Juan Perdomo, Joan Carles Reverter, Ton Lisman
Topics & Concepts
ThromboelastometryMedicineFibrinolysisVon Willebrand factorCoagulationPlatelet activationEx vivoAntithrombinThrombinPlateletInternal medicinePlasminAntithromboticIn vivoImmunologyHeparinPharmacologyGastroenterologyChemistryBiochemistryBiologyEnzymeBiotechnologyCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisBlood properties and coagulation